196 related articles for article (PubMed ID: 30245753)
21. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
[TBL] [Abstract][Full Text] [Related]
22. [OLC1 protein levels in plasma of patients with non-small cell lung cancer and its clinical application].
Yang L; Xiao T; Tan J; Chen S; Gao Y; Cheng S; Liu X; Sun K
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):362-5. PubMed ID: 25030592
[TBL] [Abstract][Full Text] [Related]
23. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
24. Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma.
Chung K; Nishiyama N; Yamano S; Komatsu H; Hanada S; Wei M; Wanibuchi H; Suehiro S; Kakehashi A
Cancer Biomark; 2011-2012; 10(2):101-7. PubMed ID: 22430137
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients.
Zhong L; Peng X; Hidalgo GE; Doherty DE; Stromberg AJ; Hirschowitz EA
Cancer Detect Prev; 2003; 27(4):285-90. PubMed ID: 12893076
[TBL] [Abstract][Full Text] [Related]
26. Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.
Powrózek T; Krawczyk P; Kowalski DM; Kuźnar-Kamińska B; Winiarczyk K; Olszyna-Serementa M; Batura-Gabryel H; Milanowski J
Tumour Biol; 2016 Feb; 37(2):2049-55. PubMed ID: 26341493
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of urine heat shock protein 70 and prostatic exosomal protein in chronic prostatitis.
Tang Y; Pan A; Liu Y; Yin L
J Clin Lab Anal; 2021 Jun; 35(6):e23778. PubMed ID: 33822413
[TBL] [Abstract][Full Text] [Related]
28. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
[TBL] [Abstract][Full Text] [Related]
29. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
30. AKAP4 is a circulating biomarker for non-small cell lung cancer.
Gumireddy K; Li A; Chang DH; Liu Q; Kossenkov AV; Yan J; Korst RJ; Nam BT; Xu H; Zhang L; Ganepola GA; Showe LC; Huang Q
Oncotarget; 2015 Jul; 6(19):17637-47. PubMed ID: 26160834
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer.
Zhang L; Pu D; Liu D; Wang Y; Luo W; Tang H; Huang Y; Li W
Lung Cancer; 2019 Sep; 135():130-137. PubMed ID: 31446985
[TBL] [Abstract][Full Text] [Related]
32. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
33. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
34. Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis.
Wu LX; Li XF; Chen HF; Zhu YC; Wang WX; Xu CW; Xie DF; Wan Y; Du KQ
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):67-70. PubMed ID: 30672447
[TBL] [Abstract][Full Text] [Related]
35. Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis.
Pan YW; Zhou ZG; Wang M; Dong JQ; Du KP; Li S; Liu YL; Lv PJ; Gao JB
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819723
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.
; Guida F; Sun N; Bantis LE; Muller DC; Li P; Taguchi A; Dhillon D; Kundnani DL; Patel NJ; Yan Q; Byrnes G; Moons KGM; Tjønneland A; Panico S; Agnoli C; Vineis P; Palli D; Bueno-de-Mesquita B; Peeters PH; Agudo A; Huerta JM; Dorronsoro M; Barranco MR; Ardanaz E; Travis RC; Byrne KS; Boeing H; Steffen A; Kaaks R; Hüsing A; Trichopoulou A; Lagiou P; La Vecchia C; Severi G; Boutron-Ruault MC; Sandanger TM; Weiderpass E; Nøst TH; Tsilidis K; Riboli E; Grankvist K; Johansson M; Goodman GE; Feng Z; Brennan P; Johansson M; Hanash SM
JAMA Oncol; 2018 Oct; 4(10):e182078. PubMed ID: 30003238
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis value of serum NKX2-1 for primary lung cancer].
Yang L; Ruan WJ; Chen EG; Ying KJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):535-9. PubMed ID: 23086646
[TBL] [Abstract][Full Text] [Related]
38. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
39. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
40. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
